Japanese Bleeding Disorders Registry Study

JRCT ID: jRCT1040240120

Registered date:06/11/2024

Basic Information

• Recruitment status: Pending
• Health condition(s) or Problem(s) studied: Congenital Hemophilia A/B, von Willebrand's disease, Related Diseases, Hemophilia carrier
• Date of first enrollment: 01/10/2024
• Target sample size: 10000
• Study type: Observational

Outcome(s)

Primary Outcome

Actual use of each drug in bleeding disorders
Information, etc. on patient demographics/treatment status/complications/efficacy/bleeding disorders-related tests
Frequency and patient demographics of thromboembolic events and intracranial hemorrhage

Key inclusion & exclusion criteria

• Age minimum: Not applicable
• Age maximum: Not applicable
• Gender: Both

Include criteria

Person corresponding to any of 1), 2), and 3), and 4) of the following items
1) Person with hemorrhagic diathesis due to congenital blood coagulation factor abnormalities
2) von Willebrand disease patient
3) Hemophilia carrier
4) Study subject who has provided consent for participation in the study using the informed consent form by him/herself or his/her legal representative; however, if it is judged that a minor study subject can express his/her intention, the consent to participate in the study should be obtained from the study subject him/herself using an informed assent form.

Exclude criteria

1) Person with acquired hemorrhagic diathesis
2) Person with thrombotic diathesis

Related Information

• Primary Sponsor: MATSUMOTO TAKESHI
• Source(s) of Monetary Support: Clinical Inovation Network